Effect of 20(S)-ginsenoside Rg3 on streptozotocin-induced experimental type 2 diabetic rats: A urinary metabonomics study by rapid-resolution liquid chromatography/mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 26, Issue 23, 2012, Pages 2683-2689

  Niu, Jun ^a,b   Pi, Zi Feng ^a   Yue, Hao ^c   Yang, Hongmei ^a   Wang, Yang ^c   Yu, Qing ^a,b   Liu, Shu Ying ^a,c  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c CHANGCHUN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LIQUID CHROMATOGRAPHY; MULTIVARIANT ANALYSIS; NUCLEIC ACIDS; PHYSIOLOGY; RATS; SPECTROMETRY;

ACTIVE COMPONENTS; GINSENOSIDES; HYPERGLYCAEMIA; LIQUID CHROMATOGRAPHY - MASS SPECTROMETRIES; METABONOMIC STUDY; PANAX GINSENG; PROTECTIVE EFFECTS; RAPID RESOLUTION LIQUID CHROMATOGRAPHIES; STREPTOZOTOCIN; TYPE 2 DIABETIC RATS;

METABOLISM;

EID: 84868345998     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.6392     Document Type: Article

References (38)

1. K. Alberti, P. Z. Zimmet,. Definition, diagnosis and classification of diabetes mellitus and its complications part 1: Diagnosis and classification of diabetes mellitus-Provisional report of a WHO consultation. Diabetic Med. 1998, 15, 539.
2. Diabetes Atlas, (3rd edn.). International Diabetes Federation, Brussels, 2006.
3. G. Ning, J. Hong, Y. Bi, W. Gu, Y. Zhang, Z. Zhang, Y. Huang, W. Wang, X. Li,. Progress in diabetes research in China. J. Diabetes 2009, 1, 163.
4. A. S. Attele, J. A. Wu, C. S. Yuan,. Ginseng pharmacology-Multiple constituents and multiple actions. Biochem. Pharmacol. 1999, 58, 1685.
5. T. Yokozawa, T. Kobayashi, H. Oura, Y. Kawashima,. Studies on the mechanism of the hypoglycemic activity of ginsenoside-rb2 in streptozotocin-diabetic rats. Chem. Pharm. Bull. 1985, 33, 869.
6. A. S. Attele, Y. P. Zhou, J. T. Xie, J. A. Wu, L. Zhang, L. Dey, W. Pugh, P.A. Rue, K. S. Polonsky, C. S. Yuan,. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002, 51, 1851.
7. S. H. Chung, C. G. Choi, S. H. Park,. Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Arch. Pharm. Res. 2001, 24, 214.
8. K. S. Kang, N. Yamabe, H. Y. Kim, J. H. Park, T. Yokozawa,. Therapeutic potential of 20(S)-ginsenoside Rg(3) against streptozotocin-induced diabetic renal damage in rats. Eur. J. Pharmacol. 2008, 591, 266.
9. S. Lim, J. W. Yoon, S. H. Choi, B. J. Cho, J. T. Kim, H. S. Chang, H. S. Park, K. S. Park, H. K. Lee, Y. B. Kim, H. C. Jang,. Effect of ginsam, a vinegar extract from Panax ginseng, on body weight and glucose homeostasis in an obese insulin-resistant rat model. Metabolism 2009, 58, 8.
10. J. T. Hwang, M. S. Lee, H. J. Kim, M. J. Sung, H. Y. Kim, M. S. Kim, D. Y. Kwon,. Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways. Phytother. Res. 2009, 23, 262.
11. M. Kim, B. Y. Ahn, J. S. Lee, S. S. Chung, S. Lim, S. G. Park, H. S. Jung, H. K. Lee, K. S. Park,. The ginsenoside Rg3 has a stimulatory effect on insulin signaling in L6 myotubes. Biochem. Biophys. Res. Commun. 2009, 389, 70.
12. M. W. Park, J. Ha, S. H. Chung,. 20(S)-ginsenoside Rg3 enhances glucose-stimulated insulin secretion and activates AMPK. Biol. Pharm. Bull. 2008, 31, 748.
13. J. K. Nicholson, J. C. Lindon, E. Holmes,. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29, 1181.
14. J. K. Nicholson, J. Connelly, J. C. Lindon, E. Holmes,. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 2002, 1, 153.
15. J. L. Griffin, M. E. Bollard,. Metabonomics: its potential as a tool in toxicology for safety assessment and data integration. Curr. Drug Metab. 2004, 5, 389.
16. P. Yin, X. Zhao, Q. Li, J. Wang, J. Li, G. Xu,. Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS). J. Proteome Res. 2006, 5, 2135.
17. M. Chen, M. Su, L. Zhao, J. Jiang, P. Liu, J. Cheng, Y. Lai, Y. Liu, W. Jia,. Metabonomic study of aristolochic acid-induced nephrotoxicity in rats. J. Proteome Res. 2006, 5, 995.
18. D. I. Ellis, W. B. Dunn, J. L. Griffin, J. W. Allwood, R. Goodacre,. Metabolic fingerprinting as a diagnostic tool. Pharmacogenomics 2007, 8, 1243.
19. Y. Gu, Y. Zhang, X. Shi, X. Li, J. Hong, J. Chen, W. Gu, X. Lu, G. Xu, G. Ning,. Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics. Talanta 2010, 81, 766.
20. S. Cai, T. G. Huo, J. H. Xu, X. M. Lu, S. N. Zheng, F. M. Li,. Effect of mitiglinide on streptozotocin-induced experimental type 2 diabetic rats: A urinary metabonomics study based on ultra-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877, 3619.
21. X. J. Zhao, Y. Zhang, X. L. Meng, P. Y. Yin, C. Deng, J. Chen, Z. Wang, G. W. Xu,. Effect of a traditional Chinese medicine preparation Xindi soft capsule on rat model of acute blood stasis: A urinary metabonomics study based on liquid chromatography-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 873, 151.
22. P. J. Tuitoek, S. Ziari, A. Tsin, R. V. Rajotte, M. Y. Suh, T. K. Basu,. Streptozotocin-induced diabetes in rats is associated with impaired metabolic availability of vitamin A (retinol). Brit. J. Nutr. 1996, 75, 615.
23. HMDB. Available: http://www.hmdb.ca/
24. METLIN. Available: http://metlin.scripps.edu/
25. Massbank. Available: http://www.massbank.jp
26. KEGG. Available: http://www.kegg.com/
27. B. Porcelli, L. F. Muraca, B. Frosi, E. Marinello, R. Vernillo, A. De Martino, S. Catinella, P. Traldi,. Fast-atom bombardment mass spectrometry for mapping of endogenous methylated purine bases in urine extracts. Rapid Commun. Mass Spectrom. 1997, 11, 398.
28. R. W. Park, J. F. Holland, A. Jenkins,. Urinary purines in leukemia. Cancer Res. 1962, 22, 469.
29. R. A. Bennett, A. E. Pegg,. Alkylation of DNA in rat tissues following administration of streptozotocin. Cancer Res. 1981, 41, 2786.
30. T. Niwa, N. Takeda, H. Yoshizumi,. RNA metabolism in uremic patients: accumulation of modified ribonucleosides in uremic serum. Technical note. Kidney Int. 1998, 53, 1801.
31. F. Palm, H. Ortsater, P. Hansell, P. Liss, P.O. Carlsson,. Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model. Diabetes Metab. Res. Rev. 2004, 20, 452.
32. J. R. Bales, D. P. Higham, I. Howe, J. K. Nicholson, P. J. Sadler,. Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin. Chem. 1984, 30, 426.
33. A. V. Greco, G. Mingrone, E. Capristo, G. Benedetti, A. De Gaetano, G. Gasbarrini,. The metabolic effect of dodecanedioic acid infusion in non-insulin-dependent diabetic patients. Nutrition 1998, 14, 351.
34. M. V. St-Pierre, G. A. Kullak-Ublick, B. Hagenbuch, P. J. Meier,. Transport of bile acids in hepatic and non-hepatic tissues. J. Exp. Biol. 2001, 204, 1673.
35. T. Claudel, B. Staels, F. Kuipers,. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 2020.
36. J. Y. Chiang,. Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 284, G349.
37. A. R. Ström, I. Kaasen,. Trehalose metabolism in Escherichia coli: Stress protection and stress regulation of gene expression. Mol. Microbiol. 1993, 8, 205.
38. J. M. Oke, R. A. Watt,. Hypoglycaemic activity of alpha, alpha trehalose-6-phosphate. Afr. J. Med. Med. Sci. 1998, 27, 219.